Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children
NCT ID: NCT00944606
Last Updated: 2012-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2009-07-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Administration of oral Vitamin D supplements will improve vague musculoskeletal pain in children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia
NCT01274104
Vitamin D Replacement in Statin-Induced Myopathy
NCT01400009
Effects of Vitamin D Supplementation on Muscle Protein Synthesis
NCT06746389
Vitamin D Replacement: The Effect on Statin-Related Myalgias
NCT01022398
Efficacy of Vitamin D Supplementation in Obese Children
NCT02956408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D
Vitamin D
2000-3000 IU Vitamin D daily x 6 weeks
Placebo
Placebo candy
candy gum drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
2000-3000 IU Vitamin D daily x 6 weeks
Placebo candy
candy gum drops
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy
* vague musculoskeletal pain without diagnosis
Exclusion Criteria
* endocrinopathies
5 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of New Mexico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elizabeth Szalay
Professor, Pediatric Orthopaedics & Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth A Szalay, MD
Role: PRINCIPAL_INVESTIGATOR
University of New Mexico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of New Mexico General Clinical Research Center
Albuquerque, New Mexico, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRRC 09-167
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.